• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格雷夫斯眼眶病患者眼眶成纤维细胞脂肪生成和炎症过程中的趋化因子表达

Chemokine Expression during Adipogenesis and Inflammation in Orbital Fibroblasts from Patients with Graves' Orbitopathy.

作者信息

Lee Chae Eun, Choi Soo Hyun, Yoon Jin Sook

机构信息

Yonsei University College of Medicine, Seoul, Korea.

Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Korean J Ophthalmol. 2020 Jun;34(3):192-202. doi: 10.3341/kjo.2020.0002.

DOI:10.3341/kjo.2020.0002
PMID:32495527
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7269740/
Abstract

PURPOSE

Chemokines are involved in the pathogenesis of various autoimmune diseases, including Graves' orbitopathy (GO), but comprehensive analyses of the dynamics of these cytokines and their receptors in such diseases remain lacking. In this study, we investigated the expressions of chemokines and their receptors during adipogenesis and inflammation in primary cultured orbital fibroblasts from patients with GO.

METHODS

The messenger RNA (mRNA) expression levels of chemokines were compared between GO (n = 6) and non-GO (n = 5) orbital tissues by real-time polymerase chain reaction. After adipogenesis was induced in primary cultured orbital fibroblasts from patients with GO (n =5) and following stimulation with interleukin (IL)-1β and tumor necrosis factor (TNF)-α, the mRNA expression levels of chemokines and their receptors were analyzed.

RESULTS

Chemokines were significantly downregulated in GO orbital tissues compared to non-GO orbital tissues ( < 0.05). Adipogenesis resulted in a strong increase in mRNA expression levels of chemokines and their receptors at an early stage (day 1); however, expression levels started to decrease thereafter and, eventually, decreased to below basal levels at the end of adipogenesis (day 10). Following stimulation with IL-1β and TNF-α, the mRNA expression levels of chemokines and their receptors increased, showing different responses to various proinflammatory cytokines.

CONCLUSIONS

Chemokines were strongly upregulated in the early phase of adipogenesis before decreasing continuously until the end of adipogenesis. Also, overt mature GO tissues showed reduced mRNA expression of chemokines compared to controls, which might indicate the existence of a shorter window for effective medical inflammatory treatment. The heightened levels of chemokines and their receptors observed after stimulation with IL-1β and TNF-α suggest a crucial role of proinflammatory cytokines in the pathogenesis of GO and, further, support the idea that chemokines could be used as biomarkers of GO activity.

摘要

目的

趋化因子参与包括格雷夫斯眼眶病(GO)在内的多种自身免疫性疾病的发病机制,但对这些细胞因子及其受体在这类疾病中的动态变化进行全面分析的研究仍很缺乏。在本研究中,我们调查了GO患者原代培养的眼眶成纤维细胞在脂肪生成和炎症过程中趋化因子及其受体的表达情况。

方法

通过实时聚合酶链反应比较GO组(n = 6)和非GO组(n = 5)眼眶组织中趋化因子的信使核糖核酸(mRNA)表达水平。在诱导GO患者(n = 5)原代培养的眼眶成纤维细胞发生脂肪生成后,以及在用白细胞介素(IL)-1β和肿瘤坏死因子(TNF)-α刺激后,分析趋化因子及其受体的mRNA表达水平。

结果

与非GO眼眶组织相比,GO眼眶组织中的趋化因子显著下调(<0.05)。脂肪生成在早期阶段(第1天)导致趋化因子及其受体的mRNA表达水平大幅增加;然而,此后表达水平开始下降,最终在脂肪生成结束时(第10天)降至基础水平以下。在用IL-1β和TNF-α刺激后,趋化因子及其受体的mRNA表达水平升高,显示出对各种促炎细胞因子的不同反应。

结论

趋化因子在脂肪生成的早期阶段强烈上调,然后持续下降直至脂肪生成结束。此外,与对照组相比,明显成熟的GO组织中趋化因子的mRNA表达降低,这可能表明有效药物抗炎治疗的窗口期较短。在用IL-1β和TNF-α刺激后观察到的趋化因子及其受体水平升高表明促炎细胞因子在GO发病机制中起关键作用,进一步支持了趋化因子可作为GO活动生物标志物的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e90d/7269740/85f2c7be90c2/kjo-34-192-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e90d/7269740/864ac2bfe7fb/kjo-34-192-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e90d/7269740/2d376cee74b9/kjo-34-192-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e90d/7269740/8859ca77d8c3/kjo-34-192-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e90d/7269740/85f2c7be90c2/kjo-34-192-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e90d/7269740/864ac2bfe7fb/kjo-34-192-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e90d/7269740/2d376cee74b9/kjo-34-192-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e90d/7269740/8859ca77d8c3/kjo-34-192-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e90d/7269740/85f2c7be90c2/kjo-34-192-g004.jpg

相似文献

1
Chemokine Expression during Adipogenesis and Inflammation in Orbital Fibroblasts from Patients with Graves' Orbitopathy.格雷夫斯眼眶病患者眼眶成纤维细胞脂肪生成和炎症过程中的趋化因子表达
Korean J Ophthalmol. 2020 Jun;34(3):192-202. doi: 10.3341/kjo.2020.0002.
2
High-Mobility Group Box 1 Is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.高迁移率族蛋白 B1 与格雷夫斯眼病的炎症发病机制有关。
Thyroid. 2019 Jun;29(6):868-878. doi: 10.1089/thy.2018.0285. Epub 2019 May 14.
3
Glycogen Synthase Kinase-3β Mediates Proinflammatory Cytokine Secretion and Adipogenesis in Orbital Fibroblasts from Patients with Graves' Orbitopathy.糖原合酶激酶-3β在 Graves 眼病患者眼眶成纤维细胞中促炎细胞因子分泌和脂肪生成中的作用。
Invest Ophthalmol Vis Sci. 2020 Jul 1;61(8):51. doi: 10.1167/iovs.61.8.51.
4
Macrophage-Orbital Fibroblast Interaction and Hypoxia Promote Inflammation and Adipogenesis in Graves' Orbitopathy.巨噬细胞-眼眶成纤维细胞相互作用与缺氧促进Graves眼病中的炎症和脂肪生成。
Endocrinology. 2022 Dec 19;164(2). doi: 10.1210/endocr/bqac203.
5
MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy.微小 RNA-27 抑制格雷夫斯眼病患者眼眶成纤维细胞的成脂分化。
PLoS One. 2019 Aug 15;14(8):e0221077. doi: 10.1371/journal.pone.0221077. eCollection 2019.
6
Inhibitory Effect of Idelalisib, a Selective Phosphatidylinositol 3-Kinase δ Inhibitor, on Adipogenesis in an In Vitro Model of Graves' Orbitopathy.依鲁替尼,一种选择性磷脂酰肌醇 3-激酶 δ 抑制剂,对格雷夫斯眼病体外模型中成脂分化的抑制作用。
Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4477-4485. doi: 10.1167/iovs.18-24509.
7
Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves' Ophthalmopathy.Graves 眼病眼眶成纤维细胞蛋白质组学与 DNA 甲基化的综合分析
Front Endocrinol (Lausanne). 2021 Feb 15;11:619989. doi: 10.3389/fendo.2020.619989. eCollection 2020.
8
Pentraxin 3 mediates inflammation and adipogenesis in Graves' orbitopathy pathogenesis.Pentraxin 3 在格雷夫斯眼病发病机制中介导炎症和脂肪生成。
J Mol Endocrinol. 2024 Oct 14;73(4). doi: 10.1530/JME-24-0039. Print 2024 Nov 1.
9
Effect of tanshinone IIA in an in vitro model of Graves' orbitopathy.丹参酮 IIA 对 Graves 眼病体外模型的作用。
Invest Ophthalmol Vis Sci. 2014 Aug 26;55(9):5900-10. doi: 10.1167/iovs.14-14008.
10
Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves' Orbitopathy.成纤维细胞生长因子受体抑制剂可减少眼眶成纤维细胞的脂肪生成并增强格雷夫斯眼病中的肌成纤维细胞分化。
Ocul Immunol Inflamm. 2021 Jan 2;29(1):193-202. doi: 10.1080/09273948.2019.1672196. Epub 2019 Oct 28.

引用本文的文献

1
Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy.细胞因子信号转导抑制因子3在格雷夫斯眼病发病机制中的作用。
Front Endocrinol (Lausanne). 2025 Mar 4;16:1527275. doi: 10.3389/fendo.2025.1527275. eCollection 2025.
2
The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves' Orbitopathy.Adipsin 和补体因子 D 在格雷夫斯眼病发病机制中的作用。
Invest Ophthalmol Vis Sci. 2023 Aug 1;64(11):13. doi: 10.1167/iovs.64.11.13.
3
Identification of immune associated potential molecular targets in proliferative diabetic retinopathy.

本文引用的文献

1
Teprotumumab for Thyroid-Associated Ophthalmopathy.替普罗单抗治疗甲状腺相关性眼病
N Engl J Med. 2017 May 4;376(18):1748-1761. doi: 10.1056/NEJMoa1614949.
2
Sphingosine-1-phosphate is involved in inflammatory reactions in patients with Graves' orbitopathy.1-磷酸鞘氨醇参与格雷夫斯眼眶病患者的炎症反应。
Inflamm Res. 2017 Jun;66(6):535-545. doi: 10.1007/s00011-017-1037-3. Epub 2017 Mar 31.
3
Is modified clinical activity score an accurate indicator of diplopia progression in Graves' orbitopathy patients?改良临床活动评分是Graves眼病患者复视进展的准确指标吗?
鉴定增殖性糖尿病性视网膜病变中的免疫相关潜在分子靶标。
BMC Ophthalmol. 2023 Jan 19;23(1):27. doi: 10.1186/s12886-023-02774-y.
4
Serum Levels of CXCL-13, RBP-4, and IL-6, and Correlation Analysis of Patients with Graves' Disease.Graves病患者血清CXCL-13、视黄醇结合蛋白-4和白细胞介素-6水平及其相关性分析
Emerg Med Int. 2022 Aug 12;2022:5131846. doi: 10.1155/2022/5131846. eCollection 2022.
Endocr J. 2016 Dec 30;63(12):1133-1140. doi: 10.1507/endocrj.EJ16-0165. Epub 2016 Sep 13.
4
Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.Graves 眼病活动期和中重度患者的治疗进展。
Lancet Diabetes Endocrinol. 2017 Feb;5(2):134-142. doi: 10.1016/S2213-8587(16)30046-8. Epub 2016 Jun 23.
5
Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.眼眶成纤维细胞在格雷夫斯眼病发病机制中作用的当前观点
Exp Eye Res. 2016 Jan;142:83-91. doi: 10.1016/j.exer.2015.02.007.
6
Current Insights into the Pathogenesis of Graves' Ophthalmopathy.格雷夫斯眼病发病机制的最新见解
Horm Metab Res. 2015 Sep;47(10):773-8. doi: 10.1055/s-0035-1555762. Epub 2015 Sep 11.
7
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study.利妥昔单抗B细胞靶向治疗对活动性中重度格雷夫斯眼眶病患者的疗效:一项随机对照研究。
J Clin Endocrinol Metab. 2015 Feb;100(2):422-31. doi: 10.1210/jc.2014-3014. Epub 2014 Dec 15.
8
Chemokine network during adipogenesis in 3T3-L1 cells: Differential response between growth and proinflammatory factor in preadipocytes vs. adipocytes.3T3-L1 细胞脂肪生成过程中的趋化因子网络:前脂肪细胞与脂肪细胞中生长因子和促炎因子的差异反应。
Adipocyte. 2014 Apr 1;3(2):97-106. doi: 10.4161/adip.28110. Epub 2014 Feb 20.
9
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.趋化因子(C-X-C 基序)配体(CXCL)10 在自身免疫性疾病中的作用。
Autoimmun Rev. 2014 Mar;13(3):272-80. doi: 10.1016/j.autrev.2013.10.010. Epub 2013 Nov 2.
10
Circulating CXCL9 and CXCL10 as markers of activity of Graves' orbitopathy during treatment with corticosteroids and teleradiotherapy.循环 CXCL9 和 CXCL10 作为 Graves 眼病在皮质类固醇和远程放射治疗期间活动的标志物。
Horm Metab Res. 2012 Dec;44(13):957-61. doi: 10.1055/s-0032-1316352. Epub 2012 Jun 29.